|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/09/15 Organovo Holdings, Inc. 10-Q 9/30/15 48:4.4M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 346K
2: EX-10.2 Material Contract HTML 128K
3: EX-10.3 Material Contract HTML 21K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
31: R1 Document and Entity Information HTML 38K
24: R2 Condensed Consolidated Balance Sheets HTML 98K
29: R3 Condensed Consolidated Balance Sheets HTML 28K
(Parenthetical)
33: R4 Unaudited Condensed Consolidated Statements of HTML 60K
Operations
44: R5 Unaudited Condensed Consolidated Statements of HTML 98K
Cash Flows
25: R6 Unaudited Condensed Consolidated Statements of HTML 21K
Cash Flows (Parenthetical)
28: R7 Description of Business and Summary of Significant HTML 114K
Accounting Policies
22: R8 Derivative Liability HTML 65K
16: R9 Stockholders' Equity HTML 168K
45: R10 Commitments and Contingencies HTML 51K
35: R11 Concentrations HTML 23K
34: R12 Recent Accounting Pronouncements HTML 28K
39: R13 Subsequent Events HTML 21K
40: R14 Description of Business and Summary of Significant HTML 184K
Accounting Policies (Policies)
38: R15 Description of Business and Summary of Significant HTML 74K
Accounting Policies (Tables)
41: R16 Derivative Liability (Tables) HTML 59K
30: R17 Stockholders' Equity (Tables) HTML 149K
32: R18 Commitments and Contingencies (Tables) HTML 34K
37: R19 Description of Business and Summary of Significant HTML 88K
Accounting Policies - Additional Information
(Detail)
48: R20 Description of Business and Summary of Significant HTML 31K
Accounting Policies - Estimated Fair Values of
Liabilities Measured on Recurring Basis (Detail)
42: R21 Description of Business and Summary of Significant HTML 33K
Accounting Policies - Activity for Liabilities
Measured at Estimated Fair Value Using
Unobservable Inputs (Detail)
26: R22 Derivative Liability - Additional Information HTML 37K
(Detail)
36: R23 Derivative Liability - Assumptions Used to Value HTML 33K
Derivative Liabilities at Closing Dates of Private
Placements (Detail)
27: R24 Stockholders' Equity - Additional Information HTML 159K
(Detail)
15: R25 Stockholders' Equity - Summary of Company's HTML 29K
Restricted Stock Award Activity (Detail)
43: R26 Stockholders' Equity - Additional Information 1 HTML 57K
(Detail)
46: R27 Stockholders' Equity - Summary of Stock Option HTML 54K
Activity (Detail)
19: R28 Stockholders' Equity - Fair Value of Employee HTML 33K
Stock Options (Detail)
18: R29 Stockholders' Equity - Additional Information 2 HTML 80K
(Detail)
20: R30 Stockholders' Equity - Summary of Warrant Activity HTML 46K
(Detail)
21: R31 Stockholders' Equity - Common Stock Reserved for HTML 27K
Future Issuance (Detail)
23: R32 Commitments and Contingencies - Additional HTML 58K
Information (Detail)
14: R33 Commitments and Contingencies - Future Minimum HTML 38K
Rental Payments Required under Operating Leases
that have Initial or Remaining Non-Cancelable
Lease Terms in Excess of One Year (Detail)
47: XML IDEA XML File -- Filing Summary XML 81K
13: EXCEL IDEA Workbook of Financial Reports XLSX 58K
7: EX-101.INS XBRL Instance -- onvo-20150930 XML 1.14M
9: EX-101.CAL XBRL Calculations -- onvo-20150930_cal XML 96K
10: EX-101.DEF XBRL Definitions -- onvo-20150930_def XML 335K
11: EX-101.LAB XBRL Labels -- onvo-20150930_lab XML 770K
12: EX-101.PRE XBRL Presentations -- onvo-20150930_pre XML 590K
8: EX-101.SCH XBRL Schema -- onvo-20150930 XSD 106K
17: ZIP XBRL Zipped Folder -- 0001564590-15-010138-xbrl Zip 105K
Exhibit 10.3
ORGANOVO HOLDINGS, inc.
SEVERANCE AND CHANGE IN CONTROL PLAN
PARTICIPATION AGREEMENT
This Participation Agreement (“Participation Agreement”) is entered into effective as of November 4, 2015, by and between ___________ (the “Participant”) and Organovo Holdings, Inc. (the “Company”) pursuant to the Organovo Holdings, Inc., Severance and Change of Control Plan (the “Plan”). All capitalized terms used in this Participation Agreement not otherwise defined herein shall have the meanings set forth in Section 1 of the Plan, except as otherwise specified.
Pursuant to the Plan, the Participant has been designated as a Tier [1] [2] [3] [4] Executive, eligible to receive Severance Benefits as specified in Section 6 of the Plan provided the Participant agrees to comply with all of the terms and conditions of the Plan by entering into this Participation Agreement.
Accordingly, the Participant hereby agrees that [s]he has received a copy of the Plan and has reviewed and understands all of the terms and conditions of the Plan, and hereby agrees to comply with and be bound by all of the terms and conditions of the Plan, including, but not limited to, the Restrictive Covenants set forth in Section 7(b) of the Plan; At-Will Employment status set forth in Section 7(c) of the Plan; Nonduplication; No Impact on Benefits provisions of Section 7(d) of the Plan; Benefit Claims provisions of Section 7 of the Plan; Right of Recoupment set forth in Section 9 of the Plan; Right of Offset set forth in Section 10(e) of the Plan; and Arbitration provisions set forth in Section 10(k) of the Plan.
The Participant also agrees and understands that if [s]he is covered by an existing employment or severance agreement with the Company on the Effective Date, [his][her] existing rights under that agreement are terminated and replaced with the provisions of this Plan; provided, however, that for the duration of the original remaining term of such employment or severance agreement only, the timing and form of severance (i.e., lump sum or installments) in the employment or severance agreement shall supersede the timing and form of payment provisions in Section 6 of the Plan and control the timing and form of payment of the Cash Severance to the extent required to comply with the requirements of Code section 409A.
The Participant also agrees that, by execution of this Participation Agreement, the award agreements for all outstanding equity awards held by the Participant as of the Effective Date are hereby amended to provide that the terms “Cause”, “Change of Control”, “Disability” and “Good Reason” as used in those award agreements shall have the meanings set forth in Section 2 of the Plan.
IN WITNESS WHEREOF, the Participant hereby agrees to the requirements for participation in the Plan as set forth in this Participation Agreement and the Plan, and executes this Participation Agreement this ___ day of ________, 2015.
|
|
|
|
|
|
|
|
|
|
|
[PARTICIPANT] |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/9/15 | 8-K | ||
| 11/4/15 | ||||
| For Period end: | 9/30/15 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/30/24 Organovo Holdings, Inc. S-1/A 81:12M Donnelley … Solutions/FA 4/12/24 Organovo Holdings, Inc. S-1 76:11M Donnelley … Solutions/FA 7/31/23 Organovo Holdings, Inc. 10-K/A 3/31/23 12:1.4M Donnelley … Solutions/FA 7/14/23 Organovo Holdings, Inc. 10-K 3/31/23 75:12M Donnelley … Solutions/FA 6/10/22 Organovo Holdings, Inc. 10-K 3/31/22 76:8.3M ActiveDisclosure/FA 7/29/21 Organovo Holdings, Inc. 10-K/A 3/31/21 12:1.3M ActiveDisclosure/FA 6/15/21 Organovo Holdings, Inc. 10-K 3/31/21 74:7.1M ActiveDisclosure/FA 9/03/20 Organovo Holdings, Inc. DEFA14A 9/03/20 1:120K ActiveDisclosure/FA 9/03/20 Organovo Holdings, Inc. 8-K:3,5,9 9/02/20 2:85K ActiveDisclosure/FA |